| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7.69M |
$146M |
$19.00 |
28 Jun 2021 |
Indirect |
| Savara Inc |
10%+ Owner |
Common Stock |
24.5M |
$109M |
$4.45 |
17 Jul 2023 |
Indirect |
| Korro Bio, Inc. |
10%+ Owner |
Common Stock |
1.09M |
$61.1M |
$56.00 |
22 Apr 2024 |
Indirect |
| MBX Biosciences, Inc. |
10%+ Owner |
Common Stock |
3.61M |
$38.6M |
$10.69 |
16 Sep 2024 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
Common Stock |
10.4M |
$21.1M |
$2.02 |
11 Apr 2022 |
Indirect |
| ARDELYX, INC. |
10%+ Owner |
Common Stock |
2.26M |
$15M |
$6.64 |
15 Dec 2021 |
Indirect |
| Coursera, Inc. |
10%+ Owner |
Common Stock |
100K |
$1.85M |
$18.39 |
15 Feb 2023 |
Indirect |
| Metacrine, Inc. |
10%+ Owner |
Common Stock |
2.56M |
$1.2M |
$0.47 |
22 Dec 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Class A Common Stock |
36.7K |
$451K |
$12.28 |
02 May 2022 |
Indirect |
| IonQ, Inc. |
10%+ Owner |
Common Stock |
9.53K |
$126K |
$13.21 |
16 Nov 2022 |
Indirect |
| AVEO PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock |
3.22K |
$48.3K |
$15.00 |
19 Oct 2022 |
Indirect |
| Sagimet Biosciences Inc. |
10%+ Owner |
Series A Common Stock |
11.3K |
$46.3K |
$4.10 |
29 Jan 2024 |
Indirect |
| Mirum Pharmaceuticals, Inc. |
10%+ Owner |
Common Stock |
1.55K |
$43.4K |
$28.04 |
13 Jun 2023 |
Indirect |
| Desktop Metal, Inc. |
10%+ Owner |
Class A Common Stock |
7.33K |
$5.38K |
$0.73 |
08 Jun 2021 |
Indirect |
| Eargo, Inc. |
10%+ Owner |
Common Stock |
1.63K |
$4.22K |
$2.59 |
24 May 2021 |
Indirect |
| NeueHealth, Inc. |
Director, 10%+ Owner |
Common Stock |
0 |
$0 |
$6.84 |
02 Oct 2025 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
3.5-Year Common Stock Warrant |
1.85M |
|
|
18 Oct 2021 |
Indirect |
| Trevi Therapeutics, Inc. |
10%+ Owner |
7-Year Common Stock Warrant |
1.85M |
|
|
18 Oct 2021 |
Indirect |
| Akouos, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$12.50 |
30 Nov 2022 |
Indirect |
| Arcellx, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$55.27 |
22 Dec 2022 |
Indirect |
| GENOCEA BIOSCIENCES, INC. |
10%+ Owner |
Common Stock |
0 |
|
$1.25 |
25 May 2022 |
Indirect |
| MBX Biosciences, Inc. |
10%+ Owner |
Series A Convertible Preferred Stock |
0 |
|
|
16 Sep 2024 |
Indirect |
| MBX Biosciences, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
16 Sep 2024 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series A-2 convertible preferred stock |
0 |
|
|
28 Jun 2021 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series B convertible preferred stock |
0 |
|
$2.00 |
28 Jun 2021 |
Indirect |
| Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series C convertible preferred Stock |
0 |
|
$2.96 |
28 Jun 2021 |
Indirect |
| NeueHealth, Inc. |
Director, 10%+ Owner |
Series A Convertible Perpetual Preferred Stock |
0 |
|
|
02 Oct 2025 |
Indirect |
| NeueHealth, Inc. |
Director, 10%+ Owner |
Series B Convertible Perpetual Preferred Stock |
0 |
|
|
02 Oct 2025 |
Indirect |
| NeueHealth, Inc. |
Director, 10%+ Owner |
Warrant (Right to Buy) |
0 |
|
|
02 Oct 2025 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Common Stock |
0 |
|
$34.32 |
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series B Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series C Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series D Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series E Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Series F Redeemable Convertible Preferred Stock |
0 |
|
|
02 Aug 2021 |
Indirect |
| Robinhood Markets, Inc. |
Director |
Tranche I Convertible Promissory Note |
0 |
|
|
02 Aug 2021 |
Indirect |